Prophylaxis of venous thromboembolic disease;Prophyloxie de la maladie veineuse thrombo-embolique

Revue du Praticien

Volumn 53, Issue 1, 2003, Pages 51-57

  Samama, Meyer M ^a   Gerotziafas, Grigoris T ^a   Horellou, Marie Hélène ^a  

^a Service d'Hematologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GERIATRICS; HEART DISEASE; PROPHYLAXIS; RISK; THROMBOEMBOLISM; VEIN; HUMAN; PREOPERATIVE CARE; REVIEW; RISK ASSESSMENT; RISK FACTOR; VEIN THROMBOSIS;

HUMANS; PREOPERATIVE CARE; RISK ASSESSMENT; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 0037223519     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Samama MM. Prévention de la maladie veineuse thromboembolique. Rev Prat 1996; 46: 1245-53.
2. Kearon C. Epidemiology of venous thromboembolism. Semin Vasc Med 2001; 1: 7-25.
3. Ferrara E, Baudouy M, Ceboni P et al. On behalf of the French Mulicentre Registry. Clinical epidemiology of venous thromboembolic disease. Results of a French multicentre registry. Eur Heart J 1997; 18: 685-91.
4. Stein PD, Henry JW. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995; 108: 978-81.
5. Silverstein MD, Hiet JA, Mohr DC, Petterson TM, O'Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism. A 25-year population based study. Arch Intern Med 1998; 158: 585-93.
6. Heit JA, O'Fallon WM, Petterson TM et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism. Arch Intern Med 2002; 162: 1245-8.
7. Pottier P, Planchon B, Pistorius MA, Grolleau JY. Facteurs de risque et incidence de la maladie thrombo-embolique veineuse en médecine interne: Une étude descriptive prospective sur 947 patients hospitalisés. Rev Med Interne 2001; 22: 348-59.
8. Bergmann JF, Mahe I. Prévention de la thrombose veineuse profonde en médecine. Ann Med Interne 2000; 151: 207-14.
9. Samama MM for the Sirius Study Group. An epidemiologic study of the risk factors for deep vein thrombosis. Arch Intern Med 2000; 160: 3415-20.
10. Fagot JP, Flahaut A, Kanfer A et al. Prévention de la maladie thrombo-embolique veineuse en milieu hospitalier non chirurgical. Propositions d'indications des héparines de bas poids moléculaire. Press Med 2000; 29: 4-10.
11. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: A meta-analysis f the randomised trials. Lancet 2001; 358: 9-15.
12. Samama MM, Cohen AT, Darmon JY et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793-800.
13. Chapuis Y, Auguereau B, Clergue F et al. Prophylaxie des thromboses veineuses postopératoires: Recommandations de l'Assistance publique-Hôpitaux de Paris. STV 1995; 2: 119-20.
14. Geerts WH, Heit JA, Clagett P et al. Prevention of venous thromboemblism. Chest 2001; 119(Suppl. 1): 132S-175S.
15. Nicolaides AN, Bergqvist D, Hull R. Prevention of venous thromboembolism. International Consensus Statement, 1997:17.
16. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 1992; 305: 567-74.
17. Robertson KA, Bertot AJ, Wolfe MW, Barrack RL. Patient compliance and satisfaction with mechanical devices for preventing deep venous thrombosis after joint replacement. J South Orthop Assoc 2000; 9: 182-6.
18. Warwick D, Harrison J, Whitehouse S, Mitchelmore A, Thornton M. A randomized comparison of a foot pump and low molecular weight heparin in the prevention of deep vein thrombosis after total knee replacement. J Bone Joint Surg Br 2002; 84: 344-50.
19. Kaplan RE, Czyrny JJ, Fung TS, Unsworth JD, Hirsh J. Electrical Foot stimulation and implications for the prevention of venous thromboembolic disease.Thromb Haemost 2002; 88: 200-4.
20. Turpie AGG, Bauer KA, Eriksson BI, Lassen MR,for the Steering Committees of the Pentasaccharide Orthopedic Prophylaxis Studies. Fondaparinux vs enoxaparin for the prophylaxis of venous thromboembolism in major orthopedic surgery. A meta-analysis of 4 randomized double-blind studies. Arch Intern Med 2002; 162: 1833-40.
21. Hull RD, Pineo GF, Stein PD et al. Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: A systematic review. Arch Intern Med 2001; 161: 1952-60.
22. Strebel N, Prins M, Agnelli G, Büller HR. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low molecular weight heparin in elective hip surgery? Arch Intern Med 2002; 162: 1451-6.
23. Prandoni P, Brunchi O,Sabbion P et al. Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty. Arch Intern Med 2002; 162: 1966-71.
24. Samama ChM,Vray M, Barre J et aL For the SACRE study. Long-term venous thromboembolism prophylaxis after total hip replacement: A comparison of low molecular weight heparin with oral anticoagulant. Arch Intern Med 2002; 162: 2191-6.
25. Bergqvist D, Lowe G. Venous thromboembolism in patients undergoing laparoscopic and arthroscopic surgery and in leg casts.Arch Intern Med 2002; 162: 2173-6.
26. Kleber FX, Witt C, Flosbach CW, Koppenhagen K, Vogel G, PRINCE Study Group. Study to compare the efficacy and safety of the LMWH enoxaparin and standard heparin in the prevention of thromboembolic events in medical patients with cardiopulmonary diseases. Ann Hematol 1998; 76: A93.
27. Bergmann JF, Neuhart E. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. Thromb Haemost 1996; 76: 529-34.